Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Angiogenesis. 2014 Nov 19;18(2):125–136. doi: 10.1007/s10456-014-9450-5

Fig. 5.

Fig. 5

Radar plot of the percent changes in the median values of non-vascular and vascular MRI biomarkers for control (gray fill) and SP2024-treated (red line) groups. This clearly illustrates the sensitivity of vasculature-specific MRI biomarkers to the anti-angiogenic effects of SP2024 relative to the non-vascular or conventional MRI biomarkers